Erectile Dysfunction and Subclinical Cardiovascular Disease
- PMID: 29396281
- DOI: 10.1016/j.sxmr.2018.01.001
Erectile Dysfunction and Subclinical Cardiovascular Disease
Abstract
Background: An association between erectile dysfunction (ED) and cardiovascular (CV) disease (CVD) has long been recognized, and studies suggest that ED is an independent marker of CVD risk. More significantly, ED is a marker for both obstructive and non-obstructive coronary artery disease (CAD) and may reveal the presence of subclinical CAD in otherwise asymptomatic men.
Aim: To discuss the role of ED as an early marker of subclinical CVD; describe an approach to quantifying that burden; and propose an algorithm for the evaluation and management of CV risk in men 40-60 years of age with vasculogenic ED, those presumed to have the highest risk for a CV event.
Methods: A comprehensive review of original literature and expert consensus documents was conducted and incorporated into clinical recommendations for ED management in the context of CV risk.
Outcomes: Assessment and management of ED may help identify and reduce the risk of future CV events. Initial evaluation should distinguish between vasculogenic ED and ED of other etiologies.
Results: For men with predominantly vasculogenic ED, we recommend that initial CV risk stratification be based on the 2013 American College of Cardiology/American Heart Association atherosclerotic CV disease risk score. Management of men with ED who are at low risk for CVD should focus on risk factor control; men at high risk, including those with CV symptoms, should be referred to a cardiologist. Intermediate-risk men should undergo non-invasive evaluation for subclinical atherosclerosis. Evidence supports use of a prognostic markers, particularly coronary calcium score, to further understand CV risk in men with ED.
Conclusions: Clinicians must assess the presence or absence of ED in every man >40 years of age, especially those men who are asymptomatic for signs and symptoms of CAD. We support CV risk stratification and CVD risk factor reduction in all men with vasculogenic ED. Miner M, Parish SJ, Billups KL, et al. Erectile Dysfunction and Subclinical Cardiovascular Disease. Sex Med Rev 2018;7:455-463.
Keywords: American College of Cardiology/American Heart Association Score for Men; Cardiovascular Risk Stratification; Coronary Calcium Score; Erectile Dysfunction; Vasculogenic.
Copyright © 2018 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Erectile Dysfunction Predicts Cardiovascular Events as an Independent Risk Factor: A Systematic Review and Meta-Analysis.J Sex Med. 2019 Jul;16(7):1005-1017. doi: 10.1016/j.jsxm.2019.04.004. Epub 2019 May 16. J Sex Med. 2019. PMID: 31104857
-
The great opportunity of the andrological patient: cardiovascular and metabolic risk assessment and prevention.Andrology. 2017 May;5(3):408-413. doi: 10.1111/andr.12342. Epub 2017 Mar 7. Andrology. 2017. PMID: 28267892
-
Erectile dysfunction in primary care: a focus on cardiometabolic risk evaluation and stratification for future cardiovascular events.Can J Urol. 2014 Jun;21 Suppl 2:25-38. Can J Urol. 2014. PMID: 24978630
-
All men with vasculogenic erectile dysfunction require a cardiovascular workup.Am J Med. 2014 Mar;127(3):174-82. doi: 10.1016/j.amjmed.2013.10.013. Epub 2013 Nov 1. Am J Med. 2014. PMID: 24423973 Review.
-
The assessment of vascular risk in men with erectile dysfunction: the role of the cardiologist and general physician.Int J Clin Pract. 2013 Nov;67(11):1163-72. doi: 10.1111/ijcp.12200. Epub 2013 May 28. Int J Clin Pract. 2013. PMID: 23714173 Review.
Cited by
-
Increased serum asprosin is correlated with diabetes mellitus-induced erectile dysfunction.Diabetol Metab Syndr. 2024 Apr 24;16(1):91. doi: 10.1186/s13098-024-01333-9. Diabetol Metab Syndr. 2024. PMID: 38659035 Free PMC article.
-
Aortic Stiffness and the Response to Phosphodiesterase-5 Inhibitors in Patients Receiving Treatment for Erectile Dysfunction: Predictive Role or an Epiphenomenon?Arq Bras Cardiol. 2024 Apr 22;121(3):e20240092. doi: 10.36660/abc.20240092. eCollection 2024. Arq Bras Cardiol. 2024. PMID: 38655986 Free PMC article. English, Portuguese. No abstract available.
-
Circulating miRNA-21 is an innovative biomarker for cardiovascular events in erectile dysfunction patients.Front Cardiovasc Med. 2024 Mar 21;11:1301925. doi: 10.3389/fcvm.2024.1301925. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38576420 Free PMC article.
-
Genetic association of lipid-lowering drug target genes with erectile dysfunction and male reproductive health.Front Endocrinol (Lausanne). 2024 Feb 8;15:1362499. doi: 10.3389/fendo.2024.1362499. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38390206 Free PMC article.
-
Investigating the risk factors of penile arterial insufficiency and veno-occlusive dysfunction in patients with erectile dysfunction.BJUI Compass. 2023 Aug 31;5(1):34-41. doi: 10.1002/bco2.275. eCollection 2024 Jan. BJUI Compass. 2023. PMID: 38179020 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous